CCR 20th Anniversary Commentary: Paving the Way for Circulating Tumor Cells
CLINICAL CANCER RESEARCH (2015)
Journal
CLINICAL CANCER RESEARCH
Volume 21, Issue 13, Pages 2883-2885Publisher
AMER ASSOC CANCER RESEARCH
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward
Joost B. Koedijk, Inge van der Werf, Friso G. Calkoen, Stefan Nierkens, Gertjan J. L. Kaspers, Christian Michel Zwaan, Olaf Heidenreich
CANCERS (2021)
Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
Filipa D. dos Reis, Carmen Jeronimo, Margareta P. Correia
FRONTIERS IN IMMUNOLOGY (2023)
Cancer Models on Chip: Paving the Way to Large-Scale Trial Applications
Joao Ferreira Gil, Carla Sofia Moura, Vania Silverio, Gil Goncalves, Helder A. Santos
ADVANCED MATERIALS (2023)
Multi-junction solar cells paving the way for super high-efficiency
Masafumi Yamaguchi, Frank Dimroth, John F. Geisz, Nicholas J. Ekins-Daukes
JOURNAL OF APPLIED PHYSICS (2021)
Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment
Franziska Fuechsl, Angela M. Krackhardt
CANCERS (2022)
Neutrophil-derived granule cargoes: paving the way for tumor growth and progression
Kavita Rawat, Saima Syeda, Anju Shrivastava
CANCER AND METASTASIS REVIEWS (2021)
Paving the way to improve therapy for Myeloproliferative Neoplasms Comment
Megan Bywater, Steven W. Lane
NATURE COMMUNICATIONS (2022)
Paving the way for designing drugs targeting TMEM16A
Simone Pifferi, Anna Menini
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy
Limeng Cai, Minfeng Ying, Hao Wu
FRONTIERS IN ONCOLOGY (2021)
Circulating Tumor Cells for Glioma
Huikai Zhang, Fanen Yuan, Yangzhi Qi, Baohui Liu, Qianxue Chen
FRONTIERS IN ONCOLOGY (2021)
Patritumab Deruxtecan: Paving the Way for EGFR-TKI-Resistant NSCLC
Sun Min Lim, Chang Gon Kim, Jii Bum Lee, Byoung Chul Cho
CANCER DISCOVERY (2022)
Current status of n-type SnS: paving the way for SnS homojunction solar cells
Issei Suzuki, Sakiko Kawanishi, Takahisa Omata, Hiroshi Yanagi
JOURNAL OF PHYSICS-ENERGY (2022)
Paving the Way for Synthetic Intrinsically Disordered Polymers for Soft Robotics
Orkid Coskuner-Weber, Elif Yuce-Erarslan, Vladimir N. N. Uversky
POLYMERS (2023)
Paving the way for phage therapy using novel drug delivery approaches
Thomas Briot, Camille Kolenda, Tristan Ferry, Mathieu Medina, Frederic Laurent, Gilles Leboucher, Fabrice Pirot
JOURNAL OF CONTROLLED RELEASE (2022)
Paving the way for the Paris Agreement: Contributions of SDEWES science
Zvonimir Guzovic, Neven Duic, Antonio Piacentino, Natasa Markovska, Brian Vad Mathiesen, Henrik Lund
ENERGY (2023)
Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome
Sandra van Wilpe, Shabaz Sultan, Mark A. J. Gorris, Diederik M. Somford, Heidi V. N. Kusters-Vandevelde, Rutger H. T. Koornstra, Winald R. Gerritsen, Michiel Simons, Antoine G. van der Heijden, I. Jolanda M. de Vries, Niven Mehra
CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
Maarten J. van der Doelen, Irma M. Oving, Dirk N. J. Wyndaele, Jean-Paul van Basten, Frederiek Terheggen, Addy C. M. van de Luijtgaarden, Wim J. G. Oyen, W. Dick van Schelven, Franchette van den Berkmortel, Niven Mehra, Marcel J. R. Janssen, Judith B. Prins, Winald R. Gerritsen, Jose A. E. Custers, Inge M. van Oort
PROSTATE CANCER AND PROSTATIC DISEASES (2023)
Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registry
Gijs P. A. van den Bergh, Malou C. P. Kuppen, Hans M. Westgeest, Niven Mehra, Winald R. Gerritsen, Katja K. H. Aben, Inge M. van Oort, Reindert J. A. van Moorselaar, Diederik M. Somford, Alfonsus J. M. van den Eertwegh, Andre M. Bergman, Alphonsus C. M. van den Bergh, Carin A. Uyl-de Groot
PROSTATE CANCER AND PROSTATIC DISEASES (2023)
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial
Jeroen van Dorp, Christodoulos Pipinikas, Britt B. M. Suelmann, Niven Mehra, Nick van Dijk, Giovanni Marsico, Maurits L. van Montfoort, Sophie Hackinger, Linde M. Braaf, Tauanne Amarante, Charlaine van Steenis, Kirsten McLay, Antonios Daletzakis, Daan van den Broek, Maaike W. van de Kamp, Kees Hendricksen, Jeantine M. de Feijter, Thierry N. Boellaard, Richard P. Meijer, Toine G. van der Heijden, Nitzan Rosenfeld, Bas W. G. van Rhijn, Greg Jones, Michiel S. van der Heijden
NATURE MEDICINE (2023)
Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation
Steffie M. B. Peters, Maaike C. T. Mink, Bastiaan M. Prive, Maarten de Bakker, Frank de Lange, Constantijn H. J. Muselaers, Niven Mehra, J. Alfred Witjes, Martin Gotthardt, James Nagarajah, Mark W. Konijnenberg
EJNMMI RESEARCH (2023)
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study
Amina Banda, Bastiaan M. Prive, Youssra Allach, Maike J. M. Uijen, Steffie M. B. Peters, Cato C. Loeff, Martin Gotthardt, Constantijn H. J. Muselaers, J. Alfred Witjes, Inge M. van Oort, J. P. Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael C. Kreissl, Thomas Winkens, Philipp Seifert, Marcel J. R. Janssen, Willemijn A. M. van Gemert, James Nagarajah
CANCERS (2023)
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer
Levi Groen, Iris Kloots, David Englert, Kelly Seto, Lana Estafanos, Paul Smith, Gerald W. Verhaegh, Niven Mehra, Jack A. Schalken
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
Emmanuel S. Antonarakis, Se Hoon Park, Jeffrey C. Goh, Sang Joon Shin, Jae Lyun Lee, Niven Mehra, Ray McDermott, Nuria Sala-Gonzalez, Peter C. Fong, Richard Greil, Margitta Retz, Juan Pablo Sade, Patricio Yanez, Yi-Hsiu Huang, Stephen D. Begbie, Rustem Airatovich Gafanov, Maria De Santis, Eli Rosenbaum, Michael P. Kolinsky, Felipe Rey, Kun-Yuan Chiu, Guilhem Roubaud, Gero Kramer, Makoto Sumitomo, Francesco Massari, Hiroyoshi Suzuki, Ping Qiu, Jinchun Zhang, Jeri Kim, Christian H. Poehlein, Evan Y. Yu
JOURNAL OF CLINICAL ONCOLOGY (2023)
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome
Jeroen H. A. Creemers, Ankur Ankan, Kit C. B. Roes, Gijs Schroeder, Niven Mehra, Carl G. Figdor, I. Jolanda M. de Vries, Johannes Textor
NATURE COMMUNICATIONS (2023)
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer
Peter H. J. Slootbeek, Iris S. H. Kloots, Inge M. van Oort, Leonie I. Kroeze, Jack A. Schalken, Haiko J. Bloemendal, Niven Mehra
CANCERS (2023)
In Vivo Detection of Circulating Cancer-Associated Fibroblasts in Breast Tumor Mouse Xenograft: Impact of Tumor Stroma and Chemotherapy
Tao Lu, Lisa Oomens, Leon W. M. M. Terstappen, Jai Prakash
CANCERS (2023)
PARPing up the right tree; an overview of PARP inhibitors for metastatic castration-resistant prostate cancer
Peter H. J. Slootbeek, Joanneke K. Overbeek, Marjolijn J. L. Ligtenberg, Nielka P. van Erp, Niven Mehra
CANCER LETTERS (2023)
Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-Darolutamide
Eva Podgorsek, Niven Mehra, Inge M. M. van Oort, Diederik M. M. Somford, Emmy Boerrigter, Nielka P. P. van Erp
CLINICAL PHARMACOKINETICS (2023)
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?
Peter H. J. Slootbeek, Sofie H. Tolmeijer, Niven Mehra, Jack A. Schalken
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2023)
Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting
Niven Mehra, Iris Kloots, Michiel Vlaming, Shafak Aluwini, Els Dewulf, Daniela E. Oprea-Lager, Henk van der Poel, Herman Stoevelaar, Derya Yakar, Chris H. Bangma, Elise Bekers, Roderick van den Bergh, Andries M. Bergman, Franchette van den Berkmortel, Steve Boudewijns, Winand N. M. Dinjens, Jurgen Futterer, Tom van der Hulle, Guido Jenster, Leonie I. Kroeze, Michel van Kruchten, Geert van Leenders, Pim J. van Leeuwen, Wendy W. J. de Leng, R. Jeroen A. van Moorselaar, Walter Noordzij, Rogier A. Oldenburg, Inge M. van Oort, Irma Oving, Jack A. Schalken, Ivo G. Schoots, Ed Schuuring, Robert J. Smeenk, Ben G. L. Vanneste, Erik Vegt, Andre N. Vis, Kim de Vries, Peter-Paul M. Willemse, Maurits Wondergem, Margreet Ausems
EUROPEAN UROLOGY OPEN SCIENCE (2023)